Helius Medical Technologies, Inc. Expands Stroke Trial at the Medical University of South Carolina
-- Number of subjects increased from 12 to 60 ---- Portable Neuromodulation Stimulator (PoNS®) will be used to evaluate cranial-nerve...
-- Number of subjects increased from 12 to 60 ---- Portable Neuromodulation Stimulator (PoNS®) will be used to evaluate cranial-nerve...
WOBURN, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported business and financial highlights for the...
Miami-based provider improves operations with a unified multidimensional EHRWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR, today announced that UniVida...
Health Equity Action Report shows low-income children of color are at high risk of severe RSVWashington, D.C.--(Newsfile Corp. - July...
Insights.ai and SmartScan.ai optimize compliance and revenue integrity by unlocking access to deeper, more meaningful insights and automating key external...
WASHINGTON, DC / ACCESSWIRE / July 20, 2023 / Today, the Health Equity Collaborative (HEC), a diverse community comprised of...
AI Start-up Pioneering Generative AI for Healthcare Receives $13M in Early Funding, Adds Industry Luminaries as Advisors, and Kicks off...
Recent Pentech Health acquisition of ZOIA Pharma broadens distribution and access for patients to PKU GOLIKE®GENEVA, SWITZERLAND / ACCESSWIRE /...
"With nearly half of Medicare-eligible women having gone years without receiving a mammogram," noted Bob Still, the Executive Director of...
TORONTO, ON / ACCESSWIRE / July 14, 2023 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a...
Northwestern Clinics Embrace CrossTx's Chronic Care Management Solution to Enhance Patient Outcomes and Care CoordinationBOZEMAN, MT / ACCESSWIRE / July...
DermaSensor’s Device with FDA Breakthrough Designation Demonstrated 96.2% Sensitivity for Detecting Melanoma in Patients Aged 65 and OlderMIAMI--(BUSINESS WIRE)--DermaSensor Inc.,...
HITRUST Risk-based, 2-year (r2) Certification validates Claim.MD is committed to strong cybersecurity and meeting key regulations to protect sensitive dataPECOS,...
HITRUST Risk-based, 2-year (r2) Certification validates Claim.MD is committed to strong cybersecurity and meeting key regulations to protect sensitive dataPECOS,...
Details updated average sales price (ASP) trends and market share across all molecules for which biosimilars are availableIncludes Wholesale Acquisition...
Vital breakthrough for Alzheimer's patients worldwide with Eisai's Leqembi FDA approval; Cognetivity Neurosciences' AI CognICA technology poised to play pivotal...
The first and only approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional...
Collaborative Research Provides Actionable Insights for Payers and Policymakers on Optimizing Plans to Best Meet the Needs of the Rapidly...
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, July 05, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the...
Available nationwide and through most major insurance plans, Equip’s evidence-based treatment is effective among thousands of patientsSAN DIEGO, June 29,...